Related Experiment Video

Updated: Jun 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Atypical pathogens in adult patients admitted with community-acquired pneumonia]

Yi-hong Xiong1, Rui Deng, Rong-rong Fu

  • 1Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing 100044, China.

Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases
|November 25, 2010
PubMed
Abstract

Insights

Atypical pathogens like Chlamydia pneumoniae cause a significant portion of community-acquired pneumonia (CAP) in adults. Chlamydia pneumoniae appears to be the most common culprit in these infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pulmonology

Context:

  • Community-acquired pneumonia (CAP) remains a leading cause of morbidity and mortality globally.
  • Identifying the causative pathogens is crucial for effective treatment and management.
  • Atypical pathogens present diagnostic challenges compared to typical bacterial causes.

Purpose:

  • To determine the prevalence and clinical characteristics of atypical pathogen infections in adult CAP.
  • To investigate the roles of Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila in adult CAP.
  • To compare clinical parameters between typical and atypical pneumonia cases.

Summary:

  • A study of 153 adult CAP patients found 34% had atypical pathogen infections.
  • Chlamydia pneumoniae was the most frequent atypical pathogen, identified in 38 cases.
  • Atypical pneumonia cases showed no significant clinical differences from typical pneumonia, except for white blood cell count.

Impact:

  • Highlights the significant contribution of atypical pathogens, particularly Chlamydia pneumoniae, to adult CAP.
  • Underscores the need for diagnostic methods capable of detecting these pathogens.
  • Informs clinical practice regarding the differential diagnosis and potential pathogens in CAP.

More Related Videos

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: